{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T00:26:49Z","timestamp":1793406409058,"version":"4.5.0"},"reference-count":74,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","mayoclinicproceedings.org","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.mayocp.2018.03.026","type":"journal-article","created":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T07:15:06Z","timestamp":1527837306000},"page":"777-793","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":92,"title":["History, Diagnosis, and Management of Chronic Inflammatory Demyelinating Polyradiculoneuropathy"],"prefix":"10.1016","volume":"93","author":[{"given":"P. James B.","family":"Dyck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer A.","family":"Tracy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.mayocp.2018.03.026_bib1","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1093\/brain\/81.2.157","article-title":"Recurrent polyneuropathies and their corticosteroid treatment; with five-year observations of a placebo-controlled case treated with corticotrophin, cortisone, and prednisone","volume":"81","author":"Austin","year":"1958","journal-title":"Brain"},{"issue":"11","key":"10.1016\/j.mayocp.2018.03.026_bib2","first-page":"621","article-title":"Chronic inflammatory polyradiculoneuropathy","volume":"50","author":"Dyck","year":"1975","journal-title":"Mayo Clin Proc"},{"issue":"2","key":"10.1016\/j.mayocp.2018.03.026_bib3","first-page":"81","article-title":"Histologic and teased-fiber measurements of sural nerve in disorders of lower motor and primary sensory neurons","volume":"43","author":"Dyck","year":"1968","journal-title":"Mayo Clin Proc"},{"issue":"8","key":"10.1016\/j.mayocp.2018.03.026_bib4","first-page":"913","article-title":"Patients with chronic inflammatory demyelinating polyneuropathy initially diagnosed as Guillain-Barr\u00e9 syndrome","volume":"250","author":"Odaka","year":"2003","journal-title":"J\u00a0Neurol"},{"issue":"5","key":"10.1016\/j.mayocp.2018.03.026_bib5","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1212\/WNL.41.5.617","article-title":"Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP). Report from an Ad Hoc Subcommittee of the American Academy of Neurology AIDS Task Force","volume":"41","year":"1991","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.mayocp.2018.03.026_bib6","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1468-1331.2009.02930.x","volume":"17","author":"Van den Bergh","year":"2010","journal-title":"Eur J Neurol"},{"issue":"12","key":"10.1016\/j.mayocp.2018.03.026_bib7","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1212\/WNL.43.12.2664","article-title":"Uniform slowing of conduction velocities in Charcot-Marie-Tooth polyneuropathy type 1","volume":"43","author":"Kaku","year":"1993","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.mayocp.2018.03.026_bib8","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1212\/WNL.32.6.592","article-title":"The electrodiagnostic distinctions between chronic familial and acquired demyelinative neuropathies","volume":"32","author":"Lewis","year":"1982","journal-title":"Neurology"},{"key":"10.1016\/j.mayocp.2018.03.026_bib9","first-page":"616","article-title":"Serial conduction studies in human nerve during wallerian degeneration","volume":"43","author":"Wilbourn","year":"1977","journal-title":"Electroencephalogr Clin Neurophysiol"},{"issue":"pt 10","key":"10.1016\/j.mayocp.2018.03.026_bib10","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1093\/brain\/124.10.1958","article-title":"Clinical, electrophysiological and molecular genetic characteristics of 93 patients with X-linked Charcot-Marie-Tooth disease","volume":"124","author":"Dubourg","year":"2001","journal-title":"Brain"},{"issue":"6","key":"10.1016\/j.mayocp.2018.03.026_bib11","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1212\/WNL.0000000000001833","article-title":"CIDP diagnostic pitfalls and perception of treatment benefit","volume":"85","author":"Allen","year":"2015","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.mayocp.2018.03.026_bib12","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1136\/jnnp-2011-301472","article-title":"Uniform demyelination and more severe axonal loss distinguish POEMS syndrome from CIDP","volume":"83","author":"Mauermann","year":"2012","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"1","key":"10.1016\/j.mayocp.2018.03.026_bib13","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s40478-016-0389-1","article-title":"Nerve pathologic features differentiate POEMS syndrome from CIDP","volume":"4","author":"Piccione","year":"2016","journal-title":"Acta Neuropathol Commun"},{"issue":"6","key":"10.1016\/j.mayocp.2018.03.026_bib14","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1002\/1531-8249(199912)46:6<910::AID-ANA14>3.0.CO;2-2","article-title":"Prevalence of chronic inflammatory demyelinating polyneuropathy in New South Wales, Australia","volume":"46","author":"McLeod","year":"1999","journal-title":"Ann Neurol"},{"issue":"12","key":"10.1016\/j.mayocp.2018.03.026_bib15","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1136\/jnnp.2007.114868","article-title":"Idiopathic chronic inflammatory demyelinating polyneuropathy: an epidemiological study in Italy","volume":"78","author":"Chi\u00f2","year":"2007","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.mayocp.2018.03.026_bib16","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1046\/j.1468-1331.2001.00187.x","article-title":"Monsttad P. Chronic polyneuropathy in Vest-Agder, Norway","volume":"8","author":"Myglarid","year":"2001","journal-title":"Eur J Neurol"},{"issue":"1","key":"10.1016\/j.mayocp.2018.03.026_bib17","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1212\/WNL.0b013e3181aaea47","article-title":"Incidence and prevalence of CIDP and the association of diabetes mellitus","volume":"73","author":"Laughlin","year":"2009","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.mayocp.2018.03.026_bib18","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1002\/ana.22334","article-title":"Painless diabetic motor neuropathy: a variant of diabetic lumbosacral radiculoplexus neuropathy?","volume":"69","author":"Garces-Sanchez","year":"2011","journal-title":"Ann Neurol"},{"issue":"5","key":"10.1016\/j.mayocp.2018.03.026_bib19","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1002\/(SICI)1097-4598(199905)22:5<560::AID-MUS2>3.0.CO;2-Q","article-title":"Multifocal acquired demyelinating sensory and motor neuropathy: the Lewis-Sumner syndrome","volume":"22","author":"Saperstein","year":"1999","journal-title":"Muscle Nerve"},{"issue":"9","key":"10.1016\/j.mayocp.2018.03.026_bib20","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1212\/WNL.32.9.958","article-title":"Multifocal demyelinating neuropathy with persistent conduction block","volume":"32","author":"Lewis","year":"1982","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.mayocp.2018.03.026_bib21","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/jnen\/63.2.129","article-title":"Multifocal motor neuropathy: pathologic alterations at the site of conduction block","volume":"63","author":"Taylor","year":"2004","journal-title":"J\u00a0Neuropathol Exp Neurol"},{"issue":"9","key":"10.1016\/j.mayocp.2018.03.026_bib22","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1212\/01.WNL.0000142507.12763.58","article-title":"Chronic immune sensory polyradiculopathy: a possibly treatable sensory ataxia","volume":"63","author":"Sinnreich","year":"2004","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.mayocp.2018.03.026_bib23","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1136\/jnnp.55.8.677","article-title":"\u201cChronic sensory demyelinating neuropathy\u201d: chronic inflammatory demyelinating polyneuropathy presenting as a pure sensory neuropathy","volume":"55","author":"Oh","year":"1992","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"Pt 10","key":"10.1016\/j.mayocp.2018.03.026_bib24","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1093\/brain\/124.10.1968","article-title":"The clinical and laboraty features of chronic sensory ataxic neuropathy with anti-disialosyl IgM antibodies","volume":"124","author":"Willison","year":"2001","journal-title":"Brain"},{"issue":"9","key":"10.1016\/j.mayocp.2018.03.026_bib25","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1212\/WNL.0000000000002418","article-title":"Neurofascin-155 IgG4 in chronic inflammatory demyelinating polyneuropathy","volume":"86","author":"Devaux","year":"2016","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.mayocp.2018.03.026_bib26","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1212\/WNL.0000000000000205","article-title":"Neurofascin IgG4 antibodies in CIDP associate with disabling tremor and poor response to IVIg","volume":"82","author":"Querol","year":"2014","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.mayocp.2018.03.026_bib27","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/ana.23794","article-title":"Antibodies to contactin-1 in chronic inflammatory demyelinating polyneuropathy","volume":"73","author":"Querol","year":"2013","journal-title":"Ann Neurol"},{"issue":"8","key":"10.1016\/j.mayocp.2018.03.026_bib28","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1001\/archneur.1989.00520440064022","article-title":"Chronic inflammatory demyelinating polyradiculoneuropathy: clinical characteristics, course, and recommendations for diagnostic criteria","volume":"46","author":"Barohn","year":"1989","journal-title":"Arch Neurol"},{"issue":"3","key":"10.1016\/j.mayocp.2018.03.026_bib29","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/j.1085-9489.2005.10302.x","volume":"10","year":"2005","journal-title":"J\u00a0Peripher Nerv Syst"},{"issue":"3","key":"10.1016\/j.mayocp.2018.03.026_bib30","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/1097-4598(200103)24:3<311::AID-MUS1001>3.0.CO;2-A","article-title":"Clinical spectrum of chronic acquired demyelinating polyneuropathies","volume":"24","author":"Saperstein","year":"2001","journal-title":"Muscle Nerve"},{"issue":"8","key":"10.1016\/j.mayocp.2018.03.026_bib31","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1212\/WNL.37.8.1291","article-title":"Evidence for central nervous system demyelination in chronic inflammatory demyelinating polyradiculoneuropathy","volume":"37","author":"Mendell","year":"1987","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.mayocp.2018.03.026_bib32","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/ana.410110205","article-title":"Prednisone improves chronic inflammatory demyelinating polyradiculoneuropathy more than no treatment","volume":"11","author":"Dyck","year":"1982","journal-title":"Ann Neurol"},{"issue":"11","key":"10.1016\/j.mayocp.2018.03.026_bib33","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1001\/archneur.65.11.1460","article-title":"Treatment of chronic inflammatory demyelinating polyneuropathy with pulsed oral steroids","volume":"65","author":"Muley","year":"2008","journal-title":"Arch Neurol"},{"issue":"2","key":"10.1016\/j.mayocp.2018.03.026_bib34","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1001\/archneur.62.2.249","article-title":"Treatment of chronic inflammatory demyelinating polyneuropathy with high-dose intermittent intravenous methylprednisolone","volume":"62","author":"Lopate","year":"2005","journal-title":"Arch Neurol"},{"key":"10.1016\/j.mayocp.2018.03.026_bib35","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.clineuro.2014.01.001","article-title":"Treatment of chronic inflammatory demyelinating polyneuropathy with high dose intravenous methylprednisolone monthly for five years: 10-year follow up","volume":"118","author":"B\u00f6r\u00fc","year":"2014","journal-title":"Clin Neurol Neurosurg"},{"issue":"14","key":"10.1016\/j.mayocp.2018.03.026_bib36","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1212\/WNL.0b013e31824e8f84","article-title":"Long-term remission of CIDP after pulsed dexamethasone or short-term prednisolone treatment","volume":"78","author":"Eftimov","year":"2012","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.mayocp.2018.03.026_bib37","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S1474-4422(07)70329-0","article-title":"Intravenous immune globulin (10% caprylate-chromatography purified) for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (ICE study): a randomised placebo-controlled trial","volume":"7","author":"Hughes","year":"2008","journal-title":"Lancet Neurol"},{"issue":"6","key":"10.1016\/j.mayocp.2018.03.026_bib38","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S1474-4422(12)70093-5","article-title":"Intravenous immunoglobulin versus intravenous methylprednisolone for chronic inflammatory demyelinating polyradiculoneuropathy: a randomised controlled trial","volume":"11","author":"Nobile-Orazio","year":"2012","journal-title":"Lancet Neurol"},{"issue":"7","key":"10.1016\/j.mayocp.2018.03.026_bib39","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1136\/jnnp-2013-307515","article-title":"Frequency and time to relapse after discontinuing 6-month therapy with IVIg or pulsed methylprednisolone in CIDP","volume":"86","author":"Nobile-Orazio","year":"2015","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"12","key":"10.1016\/j.mayocp.2018.03.026_bib40","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1111\/ene.12513","article-title":"Subcutaneous immunoglobulin preserves muscle strength in chronic inflammatory demyelinating polyneuropathy","volume":"21","author":"Markvardsen","year":"2014","journal-title":"Eur J Neurol"},{"issue":"2","key":"10.1016\/j.mayocp.2018.03.026_bib41","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/ene.13218","article-title":"Subcutaneous immunoglobulin as first-line therapy in treatment-naive patients with chronic inflammatory demyelinating polyneuropathy: randomized controlled trial study","volume":"24","author":"Markvardsen","year":"2017","journal-title":"Eur J Neurol"},{"issue":"1","key":"10.1016\/j.mayocp.2018.03.026_bib42","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1474-4422(17)30378-2","article-title":"Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"17","author":"van Schaik","year":"2018","journal-title":"Lancet Neurol"},{"issue":"8","key":"10.1016\/j.mayocp.2018.03.026_bib43","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1056\/NEJM198602203140801","article-title":"Plasma exchange in chronic inflammatory demyelinating polyradiculoneuropathy","volume":"314","author":"Dyck","year":"1986","journal-title":"N\u00a0Engl J Med"},{"issue":"pt 4","key":"10.1016\/j.mayocp.2018.03.026_bib44","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1093\/brain\/119.4.1055","article-title":"Plasma-exchange therapy in chronic inflammatory demyelinating polyneuropathy: a double-blind, sham-controlled, cross-over study","volume":"119","author":"Hahn","year":"1996","journal-title":"Brain"},{"key":"10.1016\/j.mayocp.2018.03.026_bib45","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1002\/ana.410360607","article-title":"A plasma exchange versus immune globulin infustion tiral in chronic inflammatory demyelinating polyradiculopathy","volume":"35","author":"Dyck","year":"1994","journal-title":"Ann Neurol"},{"issue":"10","key":"10.1016\/j.mayocp.2018.03.026_bib46","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1136\/jnnp.45.10.866","article-title":"Chronic idiopathic polyneuropathy treated with azathioprine","volume":"45","author":"Pentland","year":"1982","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"suppl","key":"10.1016\/j.mayocp.2018.03.026_bib47","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1002\/ana.410090719","article-title":"Chronic relapsing (dysimmune) polyneuropathy: pathogenesis and treatment","volume":"9","author":"Dalakas","year":"1981","journal-title":"Ann Neurol"},{"issue":"12","key":"10.1016\/j.mayocp.2018.03.026_bib48","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1111\/j.1468-1331.2011.03495.x","article-title":"Immunosuppressive treatment in refractory chronic inflammatory demyelinating polyradiculoneuropathy: a nationwide retrospective analysis","volume":"18","author":"Cocito","year":"2011","journal-title":"Eur J Neurol"},{"issue":"4","key":"10.1016\/j.mayocp.2018.03.026_bib49","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1212\/01.WNL.0000134676.05850.C0","article-title":"Efficacy of mycophenolate mofetil in patients with chronic immune demyelinating polyneuropathy","volume":"63","author":"Gorson","year":"2004","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.mayocp.2018.03.026_bib50","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1046\/j.1468-1331.2002.00478.x","article-title":"Mycophenolate in treatment-resistant inflammatory neuropathies","volume":"9","author":"Umapathi","year":"2002","journal-title":"Eur J Neurol"},{"issue":"2","key":"10.1016\/j.mayocp.2018.03.026_bib51","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S1474-4422(08)70299-0","article-title":"Randomised controlled trial of methotrexate for chronic inflammatory demyelinating polyradiculoneuropathy (RMC trial): a pilot, multicentre study","volume":"8","year":"2009","journal-title":"Lancet Neurol"},{"issue":"4","key":"10.1016\/j.mayocp.2018.03.026_bib52","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1136\/jnnp.2005.074781","article-title":"Treatment of chronic inflammatory demyelinating polyradiculoneuropathy with methotrexate","volume":"77","author":"Fialho","year":"2006","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"6","key":"10.1016\/j.mayocp.2018.03.026_bib53","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1212\/WNL.51.6.1735","article-title":"Pulse cyclophosphamide therapy in chronic inflammatory demyelinating polyneuropathy","volume":"51","author":"Good","year":"1998","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.mayocp.2018.03.026_bib54","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1212\/WNL.58.12.1856","article-title":"High-dose cyclophosphamide without stem-cell rescue for refractory CIDP","volume":"58","author":"Brannagan","year":"2002","journal-title":"Neurology"},{"issue":"1-2","key":"10.1016\/j.mayocp.2018.03.026_bib55","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jns.2004.05.014","article-title":"Cyclosporin A in treatment of refractory patients with chronic inflammatory demyelinating polyradiculoneuropathy","volume":"224","author":"Matsuda","year":"2004","journal-title":"J\u00a0Neurol Sci"},{"issue":"4","key":"10.1016\/j.mayocp.2018.03.026_bib56","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/(SICI)1097-4598(199804)21:4<454::AID-MUS3>3.0.CO;2-8","article-title":"Cyclosporin A in resistant chronic inflammatory demyelinating polyradiculoneuropathy","volume":"21","author":"Barnett","year":"1998","journal-title":"Muscle Nerve"},{"issue":"3","key":"10.1016\/j.mayocp.2018.03.026_bib57","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1136\/jnnp.2009.188912","article-title":"Rituximab in patients with chronic inflammatory demyelinating polyradiculoneuropathy: a report of 13 cases and review of the literature","volume":"82","author":"Benedetti","year":"2011","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"2","key":"10.1016\/j.mayocp.2018.03.026_bib58","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1002\/mus.21073","article-title":"Rituximab efficacy in CIDP associated with idiopathic thrombocytopenic purpura","volume":"38","author":"Benedetti","year":"2008","journal-title":"Muscle Nerve"},{"issue":"3","key":"10.1016\/j.mayocp.2018.03.026_bib59","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.ejpn.2011.08.002","article-title":"Rituximab in a childhood-onset idiopathic refractory chronic inflammatory demyelinating polyneuropathy","volume":"16","author":"D'Amico","year":"2012","journal-title":"Eur J Paediatr Neurol"},{"issue":"1-2","key":"10.1016\/j.mayocp.2018.03.026_bib60","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jns.2007.02.027","article-title":"Rituximab in chronic inflammatory demyelinating polyneuropathy associated with diabetes mellitus","volume":"256","author":"M\u00fcnch","year":"2007","journal-title":"J\u00a0Neurol Sci"},{"issue":"2","key":"10.1016\/j.mayocp.2018.03.026_bib61","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1136\/jnnp.2009.174888","article-title":"Rituximab in the treatment of three coexistent neurological autoimmune diseases: chronic inflammatory demyelinating polyradiculoneuropathy, Morvan syndrome and myasthenia gravis","volume":"82","author":"Sadnicka","year":"2011","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"1","key":"10.1016\/j.mayocp.2018.03.026_bib62","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/mus.20664","article-title":"Rituximab treatment in patients with IVIg-dependent immune polyneuropathy: a prospective pilot trial","volume":"35","author":"Gorson","year":"2007","journal-title":"Muscle Nerve"},{"issue":"6","key":"10.1016\/j.mayocp.2018.03.026_bib63","first-page":"913","article-title":"Alemtuzumab in the treatment of IVIG-dependent chronic inflammatory demyelinating polyneuropathy","volume":"257","author":"Marsh","year":"2010","journal-title":"J\u00a0Neurol"},{"issue":"1-2","key":"10.1016\/j.mayocp.2018.03.026_bib64","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0022-510X(03)00010-8","article-title":"Etanercept (Enbrel) therapy for chronic inflammatory demyelinating polyneuropathy","volume":"210","author":"Chin","year":"2003","journal-title":"J\u00a0Neurol Sci"},{"issue":"5","key":"10.1016\/j.mayocp.2018.03.026_bib65","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/mus.21584","article-title":"Chronic inflammatory demyelinating polyneuropathy associated with tumor necrosis factor-\u03b1 antagonists","volume":"41","author":"Alshekhlee","year":"2010","journal-title":"Muscle Nerve"},{"issue":"8","key":"10.1016\/j.mayocp.2018.03.026_bib66","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1212\/01.WNL.0000158681.29117.8B","article-title":"Neuropathy resembling CIDP in patients receiving tumor necrosis factor-\u03b1 blockers","volume":"64","author":"Richez","year":"2005","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.mayocp.2018.03.026_bib67","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1136\/jnnp-2013-306014","article-title":"Autologous haematopoietic stem cell transplantation: a viable treatment option for CIDP","volume":"85","author":"Press","year":"2014","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"pt 6","key":"10.1016\/j.mayocp.2018.03.026_bib68","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1093\/brain\/110.6.1617","article-title":"Chronic inflammatory demyelinating polyradiculoneuropathy: a clinical and electrophysiological study of 92 cases","volume":"110","author":"McCombe","year":"1987","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.mayocp.2018.03.026_bib69","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1136\/jnnp.2005.065441","article-title":"Long term prognosis of chronic inflammatory demyelinating polyneuropathy: a five year follow up of 38 cases","volume":"77","author":"Kuwabara","year":"2006","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"4","key":"10.1016\/j.mayocp.2018.03.026_bib70","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/mus.24707","article-title":"Office immunotherapy in chronic inflammatory demyelinating polyneuropathy and multifocal motor neuropathy","volume":"52","author":"Dyck","year":"2015","journal-title":"Muscle Nerve"},{"issue":"12","key":"10.1016\/j.mayocp.2018.03.026_bib71","first-page":"1134","article-title":"Development of weakness in patients with chronic inflammatory demyelinating polyneuropathy and only sensory symptoms at presentation: a long-term follow-up study","volume":"246","author":"van Dijk","year":"1999","journal-title":"J\u00a0Neurol"},{"issue":"pt 9","key":"10.1016\/j.mayocp.2018.03.026_bib72","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1093\/brain\/awh222","article-title":"Follow-up study and response to treatment in 23 patients with Lewis-Sumner syndrome","volume":"127","author":"Viala","year":"2004","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.mayocp.2018.03.026_bib73","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/mus.22024","article-title":"Response to treatment in patients with Lewis-Sumner syndrome","volume":"44","author":"Attarian","year":"2011","journal-title":"Muscle Nerve"},{"issue":"5","key":"10.1016\/j.mayocp.2018.03.026_bib74","doi-asserted-by":"crossref","first-page":"e149","DOI":"10.1212\/NXI.0000000000000149","article-title":"Rituximab in treatment-resistant CIDP with antibodies against paranodal proteins","volume":"2","author":"Querol","year":"2015","journal-title":"Neurol Neuroimmunol Neuroinflamm"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619618302362?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619618302362?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,6,15]],"date-time":"2018-06-15T20:21:07Z","timestamp":1529094067000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619618302362"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":74,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S0025619618302362"],"URL":"https:\/\/doi.org\/10.1016\/j.mayocp.2018.03.026","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"History, Diagnosis, and Management of Chronic Inflammatory Demyelinating Polyradiculoneuropathy","name":"articletitle","label":"Article Title"},{"value":"Mayo Clinic Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mayocp.2018.03.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Mayo Foundation for Medical Education and Research","name":"copyright","label":"Copyright"}]}}